 Jessica Kendrick
Concepts (280)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 20 | 2026 | 668 | 4.970 |
Why?
| | Kidney Failure, Chronic | 13 | 2023 | 599 | 2.920 |
Why?
| | Renal Dialysis | 10 | 2023 | 466 | 2.520 |
Why?
| | Acidosis | 3 | 2025 | 105 | 1.980 |
Why?
| | Phosphorus | 6 | 2022 | 90 | 1.980 |
Why?
| | Kidney Diseases | 8 | 2023 | 426 | 1.740 |
Why?
| | Sodium Bicarbonate | 3 | 2025 | 48 | 1.620 |
Why?
| | Kidney Transplantation | 4 | 2022 | 712 | 1.560 |
Why?
| | Hyperparathyroidism, Secondary | 4 | 2025 | 12 | 1.550 |
Why?
| | Nephrology | 2 | 2024 | 60 | 1.400 |
Why?
| | Cardiovascular Diseases | 12 | 2023 | 2191 | 1.390 |
Why?
| | Bicarbonates | 3 | 2023 | 45 | 1.310 |
Why?
| | Ferric Compounds | 2 | 2022 | 54 | 1.260 |
Why?
| | Sucrose | 2 | 2022 | 114 | 1.250 |
Why?
| | Kidney | 11 | 2024 | 1496 | 1.220 |
Why?
| | Diet | 4 | 2023 | 1278 | 1.170 |
Why?
| | Cognition | 3 | 2025 | 1271 | 1.050 |
Why?
| | Vitamin D | 11 | 2018 | 404 | 1.010 |
Why?
| | Pregnancy Complications | 3 | 2018 | 603 | 1.000 |
Why?
| | Glomerular Filtration Rate | 9 | 2024 | 765 | 0.970 |
Why?
| | Blood Pressure | 5 | 2016 | 1782 | 0.920 |
Why?
| | Hyperkalemia | 1 | 2026 | 36 | 0.910 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2026 | 69 | 0.890 |
Why?
| | Acute Kidney Injury | 3 | 2023 | 874 | 0.880 |
Why?
| | Diabetic Neuropathies | 1 | 2026 | 100 | 0.870 |
Why?
| | Potassium | 2 | 2014 | 152 | 0.800 |
Why?
| | Glomerulonephritis, IGA | 1 | 2023 | 12 | 0.770 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2024 | 148 | 0.770 |
Why?
| | Hyperphosphatemia | 2 | 2022 | 15 | 0.760 |
Why?
| | Cerebrovascular Circulation | 1 | 2025 | 290 | 0.740 |
Why?
| | Fellowships and Scholarships | 2 | 2024 | 354 | 0.740 |
Why?
| | Abortion, Legal | 1 | 2023 | 28 | 0.730 |
Why?
| | Vitamin D Deficiency | 5 | 2013 | 190 | 0.720 |
Why?
| | Cognitive Dysfunction | 2 | 2025 | 468 | 0.720 |
Why?
| | Complement Factor B | 1 | 2023 | 106 | 0.720 |
Why?
| | Calcimimetic Agents | 1 | 2021 | 3 | 0.710 |
Why?
| | Healthcare Disparities | 3 | 2022 | 736 | 0.700 |
Why?
| | Hypertension | 4 | 2016 | 1276 | 0.690 |
Why?
| | Transition to Adult Care | 1 | 2023 | 103 | 0.680 |
Why?
| | Humans | 62 | 2026 | 145763 | 0.660 |
Why?
| | Peritoneal Dialysis | 1 | 2022 | 100 | 0.650 |
Why?
| | Eating | 1 | 2023 | 387 | 0.650 |
Why?
| | Infant, Low Birth Weight | 2 | 2018 | 156 | 0.630 |
Why?
| | Infant Mortality | 2 | 2018 | 128 | 0.620 |
Why?
| | Phosphates | 3 | 2022 | 177 | 0.610 |
Why?
| | Nutritional Status | 3 | 2022 | 353 | 0.610 |
Why?
| | Pre-Eclampsia | 2 | 2018 | 206 | 0.570 |
Why?
| | Nutrition Surveys | 5 | 2014 | 279 | 0.560 |
Why?
| | Vascular Calcification | 3 | 2018 | 110 | 0.560 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2026 | 2602 | 0.550 |
Why?
| | Pregnancy Outcome | 3 | 2018 | 504 | 0.540 |
Why?
| | Bone Diseases, Metabolic | 1 | 2018 | 58 | 0.530 |
Why?
| | Calcium | 3 | 2021 | 1191 | 0.510 |
Why?
| | Aged | 23 | 2025 | 26215 | 0.500 |
Why?
| | Antihypertensive Agents | 3 | 2016 | 521 | 0.490 |
Why?
| | Renal Insufficiency | 1 | 2019 | 172 | 0.490 |
Why?
| | Living Donors | 1 | 2018 | 282 | 0.480 |
Why?
| | Middle Aged | 26 | 2025 | 36302 | 0.480 |
Why?
| | Double-Blind Method | 7 | 2025 | 2064 | 0.470 |
Why?
| | Minerals | 2 | 2015 | 48 | 0.470 |
Why?
| | Female | 35 | 2025 | 79035 | 0.460 |
Why?
| | Parathyroid Hormone | 6 | 2021 | 114 | 0.440 |
Why?
| | Male | 33 | 2025 | 73003 | 0.440 |
Why?
| | United States | 13 | 2025 | 16123 | 0.440 |
Why?
| | Fibroblast Growth Factors | 4 | 2012 | 188 | 0.430 |
Why?
| | Prospective Studies | 8 | 2023 | 8075 | 0.420 |
Why?
| | Endothelium, Vascular | 2 | 2018 | 956 | 0.410 |
Why?
| | Sodium Chloride, Dietary | 1 | 2014 | 31 | 0.410 |
Why?
| | Risk Factors | 12 | 2020 | 10917 | 0.410 |
Why?
| | Adult | 20 | 2024 | 40872 | 0.410 |
Why?
| | Diabetic Nephropathies | 3 | 2022 | 322 | 0.400 |
Why?
| | Sodium | 1 | 2014 | 198 | 0.400 |
Why?
| | Atherosclerosis | 2 | 2016 | 409 | 0.390 |
Why?
| | Potassium, Dietary | 1 | 2013 | 12 | 0.390 |
Why?
| | Incidence | 5 | 2026 | 2933 | 0.390 |
Why?
| | Sodium, Dietary | 1 | 2013 | 42 | 0.380 |
Why?
| | Kidney Function Tests | 2 | 2010 | 156 | 0.370 |
Why?
| | Heart Arrest | 1 | 2016 | 411 | 0.360 |
Why?
| | Pilot Projects | 3 | 2025 | 1897 | 0.360 |
Why?
| | Perception | 1 | 2015 | 378 | 0.350 |
Why?
| | Disease Management | 1 | 2015 | 653 | 0.330 |
Why?
| | Myocardial Infarction | 2 | 2016 | 1211 | 0.330 |
Why?
| | Clinical Trials as Topic | 2 | 2022 | 1062 | 0.320 |
Why?
| | Ankle Brachial Index | 1 | 2010 | 41 | 0.320 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 1327 | 0.310 |
Why?
| | Pregnancy | 5 | 2024 | 7215 | 0.310 |
Why?
| | Patient Selection | 1 | 2014 | 739 | 0.310 |
Why?
| | Follow-Up Studies | 6 | 2018 | 5428 | 0.300 |
Why?
| | Lovastatin | 1 | 2009 | 37 | 0.300 |
Why?
| | Internship and Residency | 1 | 2020 | 1269 | 0.300 |
Why?
| | Stroke | 2 | 2016 | 1271 | 0.300 |
Why?
| | Drug Combinations | 2 | 2022 | 396 | 0.290 |
Why?
| | Health Services Accessibility | 1 | 2017 | 1101 | 0.290 |
Why?
| | Patient Education as Topic | 1 | 2014 | 777 | 0.290 |
Why?
| | Renal Artery Obstruction | 1 | 2008 | 30 | 0.280 |
Why?
| | Health Status | 1 | 2014 | 835 | 0.280 |
Why?
| | Cohort Studies | 6 | 2019 | 6032 | 0.260 |
Why?
| | Primary Prevention | 1 | 2009 | 222 | 0.260 |
Why?
| | Colitis, Ischemic | 1 | 2007 | 5 | 0.260 |
Why?
| | Escherichia coli O157 | 1 | 2007 | 14 | 0.260 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2007 | 29 | 0.260 |
Why?
| | Proportional Hazards Models | 3 | 2016 | 1330 | 0.250 |
Why?
| | Health Surveys | 1 | 2008 | 520 | 0.240 |
Why?
| | Escherichia coli Infections | 1 | 2007 | 125 | 0.240 |
Why?
| | Attitude of Health Personnel | 1 | 2015 | 1197 | 0.240 |
Why?
| | Hemoglobins | 1 | 2009 | 386 | 0.240 |
Why?
| | Naphthyridines | 1 | 2026 | 20 | 0.240 |
Why?
| | Comorbidity | 3 | 2020 | 1662 | 0.240 |
Why?
| | Spironolactone | 1 | 2026 | 40 | 0.230 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2015 | 1420 | 0.230 |
Why?
| | Aged, 80 and over | 6 | 2025 | 8346 | 0.230 |
Why?
| | Surveys and Questionnaires | 4 | 2025 | 6085 | 0.230 |
Why?
| | Critical Illness | 2 | 2023 | 900 | 0.230 |
Why?
| | Insulin Resistance | 3 | 2024 | 1244 | 0.230 |
Why?
| | Middle Cerebral Artery | 1 | 2025 | 56 | 0.220 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2025 | 48 | 0.220 |
Why?
| | Risk | 2 | 2026 | 923 | 0.220 |
Why?
| | Primary Health Care | 1 | 2015 | 1737 | 0.200 |
Why?
| | Pulse Wave Analysis | 2 | 2023 | 267 | 0.200 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2026 | 1751 | 0.200 |
Why?
| | Albuminuria | 3 | 2020 | 189 | 0.190 |
Why?
| | Coronary Artery Disease | 1 | 2009 | 750 | 0.190 |
Why?
| | Heart Failure | 1 | 2016 | 2326 | 0.190 |
Why?
| | Plant Proteins | 1 | 2023 | 111 | 0.190 |
Why?
| | Proteinuria | 1 | 2023 | 104 | 0.190 |
Why?
| | Treatment Outcome | 7 | 2019 | 11793 | 0.190 |
Why?
| | Hyperoxia | 1 | 2024 | 107 | 0.180 |
Why?
| | Kidney Glomerulus | 1 | 2023 | 125 | 0.180 |
Why?
| | Hypoalbuminemia | 1 | 2022 | 27 | 0.180 |
Why?
| | Communication | 2 | 2022 | 977 | 0.180 |
Why?
| | Meals | 1 | 2023 | 130 | 0.180 |
Why?
| | Military Personnel | 1 | 2009 | 737 | 0.170 |
Why?
| | Serum Albumin | 1 | 2022 | 147 | 0.170 |
Why?
| | Disease Progression | 4 | 2015 | 2865 | 0.170 |
Why?
| | Prevalence | 4 | 2017 | 2874 | 0.160 |
Why?
| | Infant, Newborn | 3 | 2018 | 6464 | 0.160 |
Why?
| | Calcinosis | 2 | 2014 | 234 | 0.160 |
Why?
| | Fruit | 1 | 2021 | 146 | 0.160 |
Why?
| | Inflammation | 2 | 2009 | 2883 | 0.160 |
Why?
| | Educational Status | 1 | 2022 | 470 | 0.150 |
Why?
| | Time Factors | 3 | 2019 | 7133 | 0.150 |
Why?
| | Young Adult | 5 | 2024 | 14251 | 0.150 |
Why?
| | Complement System Proteins | 1 | 2022 | 314 | 0.150 |
Why?
| | Neuropsychological Tests | 1 | 2024 | 1137 | 0.140 |
Why?
| | Education, Medical, Graduate | 1 | 2024 | 562 | 0.140 |
Why?
| | Creatinine | 2 | 2020 | 515 | 0.140 |
Why?
| | Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2018 | 14 | 0.140 |
Why?
| | Receptors, Calcium-Sensing | 1 | 2018 | 6 | 0.140 |
Why?
| | Vitamin D-Binding Protein | 1 | 2018 | 16 | 0.140 |
Why?
| | Chelating Agents | 1 | 2019 | 76 | 0.140 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2018 | 75 | 0.140 |
Why?
| | Career Choice | 1 | 2020 | 235 | 0.140 |
Why?
| | Biomarkers | 3 | 2023 | 4302 | 0.130 |
Why?
| | Intestinal Absorption | 1 | 2018 | 103 | 0.130 |
Why?
| | Uric Acid | 1 | 2018 | 167 | 0.130 |
Why?
| | Focus Groups | 1 | 2020 | 572 | 0.130 |
Why?
| | Case-Control Studies | 4 | 2018 | 3634 | 0.130 |
Why?
| | Metformin | 1 | 2020 | 329 | 0.130 |
Why?
| | Diuretics | 1 | 2016 | 68 | 0.120 |
Why?
| | Retrospective Studies | 5 | 2021 | 17325 | 0.120 |
Why?
| | Odds Ratio | 3 | 2014 | 1083 | 0.120 |
Why?
| | Congenital Abnormalities | 1 | 2017 | 109 | 0.120 |
Why?
| | Adolescent | 6 | 2024 | 22573 | 0.120 |
Why?
| | Cross-Over Studies | 1 | 2018 | 610 | 0.120 |
Why?
| | Peptides | 1 | 2021 | 998 | 0.120 |
Why?
| | Waiting Lists | 1 | 2017 | 266 | 0.110 |
Why?
| | Prognosis | 2 | 2018 | 4329 | 0.110 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1372 | 0.110 |
Why?
| | Polymorphism, Genetic | 1 | 2018 | 615 | 0.110 |
Why?
| | Physician-Patient Relations | 1 | 2020 | 588 | 0.110 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2015 | 115 | 0.110 |
Why?
| | Obstetric Labor, Premature | 1 | 2015 | 39 | 0.110 |
Why?
| | Maternal Mortality | 1 | 2015 | 53 | 0.110 |
Why?
| | Medication Adherence | 1 | 2019 | 540 | 0.100 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 229 | 0.100 |
Why?
| | Transcription Factor CHOP | 1 | 2014 | 32 | 0.100 |
Why?
| | Cultural Competency | 1 | 2015 | 89 | 0.100 |
Why?
| | Ethics Committees, Research | 1 | 2014 | 41 | 0.100 |
Why?
| | Infant, Small for Gestational Age | 1 | 2015 | 118 | 0.100 |
Why?
| | Awareness | 1 | 2015 | 110 | 0.100 |
Why?
| | Precision Medicine | 1 | 2018 | 461 | 0.100 |
Why?
| | Professional-Patient Relations | 1 | 2015 | 147 | 0.100 |
Why?
| | Risk Assessment | 2 | 2017 | 3752 | 0.100 |
Why?
| | Pneumonia, Bacterial | 1 | 2014 | 113 | 0.100 |
Why?
| | Simvastatin | 2 | 2014 | 59 | 0.100 |
Why?
| | Health Care Surveys | 1 | 2015 | 536 | 0.100 |
Why?
| | Premature Birth | 1 | 2017 | 390 | 0.090 |
Why?
| | Cesarean Section | 1 | 2015 | 230 | 0.090 |
Why?
| | Infant | 2 | 2018 | 10090 | 0.090 |
Why?
| | Cause of Death | 1 | 2015 | 471 | 0.090 |
Why?
| | Global Health | 1 | 2015 | 403 | 0.090 |
Why?
| | Community-Acquired Infections | 1 | 2014 | 177 | 0.090 |
Why?
| | Logistic Models | 3 | 2014 | 2139 | 0.090 |
Why?
| | Endoplasmic Reticulum | 1 | 2014 | 264 | 0.090 |
Why?
| | Academic Medical Centers | 1 | 2015 | 554 | 0.090 |
Why?
| | Vascular Diseases | 1 | 2014 | 252 | 0.090 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2015 | 293 | 0.080 |
Why?
| | Chronic Disease | 4 | 2012 | 1812 | 0.080 |
Why?
| | Cooperative Behavior | 1 | 2014 | 463 | 0.080 |
Why?
| | Cross-Sectional Studies | 3 | 2013 | 5922 | 0.080 |
Why?
| | Research | 1 | 2014 | 431 | 0.080 |
Why?
| | Metabolic Diseases | 1 | 2012 | 114 | 0.080 |
Why?
| | Survival Rate | 1 | 2015 | 2094 | 0.080 |
Why?
| | Fatty Liver | 1 | 2013 | 253 | 0.080 |
Why?
| | Infant, Premature | 1 | 2015 | 620 | 0.080 |
Why?
| | Tunica Media | 1 | 2010 | 37 | 0.080 |
Why?
| | Tunica Intima | 1 | 2010 | 78 | 0.080 |
Why?
| | Systole | 1 | 2010 | 181 | 0.070 |
Why?
| | Bone and Bones | 1 | 2012 | 318 | 0.070 |
Why?
| | Radioisotope Renography | 1 | 2008 | 4 | 0.070 |
Why?
| | Complement Activation | 2 | 2022 | 399 | 0.070 |
Why?
| | Calcium, Dietary | 1 | 2009 | 52 | 0.070 |
Why?
| | Metabolic Syndrome | 1 | 2012 | 361 | 0.070 |
Why?
| | Texas | 1 | 2009 | 273 | 0.070 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2008 | 37 | 0.070 |
Why?
| | Tomography, Spiral Computed | 1 | 2008 | 30 | 0.070 |
Why?
| | Length of Stay | 1 | 2015 | 1350 | 0.070 |
Why?
| | Cholecalciferol | 1 | 2009 | 61 | 0.070 |
Why?
| | Cardiovascular System | 1 | 2010 | 139 | 0.070 |
Why?
| | Child | 3 | 2023 | 22739 | 0.070 |
Why?
| | Causality | 1 | 2008 | 127 | 0.070 |
Why?
| | Age Distribution | 1 | 2008 | 404 | 0.070 |
Why?
| | Sepsis | 1 | 2014 | 664 | 0.070 |
Why?
| | Sex Distribution | 1 | 2008 | 388 | 0.070 |
Why?
| | Vitamins | 1 | 2009 | 184 | 0.060 |
Why?
| | Anemia | 1 | 2008 | 191 | 0.060 |
Why?
| | Homeostasis | 1 | 2011 | 644 | 0.060 |
Why?
| | Biopsy, Needle | 1 | 2007 | 185 | 0.060 |
Why?
| | Anastomosis, Surgical | 1 | 2007 | 162 | 0.060 |
Why?
| | Colectomy | 1 | 2007 | 106 | 0.060 |
Why?
| | C-Reactive Protein | 1 | 2009 | 423 | 0.060 |
Why?
| | Magnetic Resonance Angiography | 1 | 2008 | 251 | 0.060 |
Why?
| | Rare Diseases | 1 | 2007 | 116 | 0.060 |
Why?
| | Oxidative Stress | 2 | 2014 | 1359 | 0.060 |
Why?
| | Coronary Disease | 1 | 2008 | 382 | 0.060 |
Why?
| | Abdominal Pain | 1 | 2007 | 149 | 0.060 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 444 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2028 | 0.060 |
Why?
| | Ischemia | 1 | 2008 | 422 | 0.060 |
Why?
| | Survival Analysis | 1 | 2008 | 1378 | 0.050 |
Why?
| | Colorado | 1 | 2015 | 4556 | 0.050 |
Why?
| | Colonoscopy | 1 | 2007 | 264 | 0.050 |
Why?
| | Dietary Supplements | 1 | 2009 | 584 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2967 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2020 | 3937 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 333 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1723 | 0.050 |
Why?
| | Consensus | 1 | 2025 | 479 | 0.050 |
Why?
| | Atypical Hemolytic Uremic Syndrome | 1 | 2022 | 21 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2009 | 2933 | 0.050 |
Why?
| | Drug Therapy, Combination | 2 | 2015 | 1043 | 0.040 |
Why?
| | Intestinal Mucosa | 1 | 2007 | 675 | 0.040 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2022 | 149 | 0.040 |
Why?
| | Allopurinol | 1 | 2018 | 70 | 0.040 |
Why?
| | Oxygen | 1 | 2024 | 981 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2021 | 924 | 0.030 |
Why?
| | Ketocholesterols | 1 | 2014 | 8 | 0.030 |
Why?
| | Ezetimibe | 1 | 2014 | 24 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2014 | 61 | 0.030 |
Why?
| | Azetidines | 1 | 2014 | 45 | 0.030 |
Why?
| | Phenotype | 1 | 2022 | 3170 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2014 | 93 | 0.030 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2014 | 104 | 0.020 |
Why?
| | Brachial Artery | 1 | 2014 | 208 | 0.020 |
Why?
| | Insulin | 1 | 2024 | 2516 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2022 | 1399 | 0.020 |
Why?
| | Aorta | 1 | 2014 | 440 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2012 | 528 | 0.020 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2013 | 265 | 0.020 |
Why?
| | Linear Models | 1 | 2012 | 849 | 0.020 |
Why?
| | Lipids | 1 | 2014 | 707 | 0.020 |
Why?
| | Scandinavian and Nordic Countries | 1 | 2008 | 14 | 0.020 |
Why?
| | Ultrasonography | 1 | 2013 | 788 | 0.020 |
Why?
| | Placebos | 1 | 2008 | 193 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1547 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2014 | 3130 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2011 | 835 | 0.010 |
Why?
| | Body Mass Index | 1 | 2013 | 2447 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 5992 | 0.010 |
Why?
| | Animals | 1 | 2014 | 38097 | 0.010 |
Why?
|
|
Kendrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|